About: http://data.cimple.eu/news-article/66dc9f1d53e5f57ea78cf9985196a888cf3da8f26c717112851ccf3f     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Four drugmakers, including Johnson & Johnson, went on trial Monday over claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed the risks of addiction. J&J, Teva, Endo and Allergan are accused of trivializing the dangers of long-term use of opioid painkillers to boost sales in a lawsuit filed by several California counties and the city of Oakland. The complaint seeks billions of dollars in damages to abate the public nuisance it says the drugmakers created. "Defendants prioritized profits over lives and deceived the public about the real dangers of opioids," Santa Clara County attorney James Williams said in a statement. Almost 500,000 people in the United States have died from overdoses involving prescription or illicit opioids over the past two decades, according to the Centers for Disease Control and Prevention. About 50,000 people died from opioid overdoses in 2019 alone. The plaintiffs -- Santa Clara, Los Angeles and Orange counties, as well as the city of Oakland -- represent 15 million people, or 40 percent of the most populous American state. In addition to the damages, they are asking for measures to prevent deceptive pharmaceutical marketing practices in the future. "While the use of opioids has taken an enormous toll on the State of California and its residents, Defendants have realized blockbuster profits. In 2014 alone, opioids generated $11 billion in revenue for drug companies like Defendants," the complaint said. The lawsuit comes at a particularly bad time for J&J. The pharmaceutical giant, also tainted by a scandal related to its talcum-based baby power, was hoping to restore its reputation with its coronavirus vaccine. But the shot has been suspended in the United States, pending an investigation, after reports that six women had developed serious blood clots. Neither J&J nor any of the other companies responded to AFP's request for comment. More than 3,000 lawsuits related to the opioid crisis have been filed in US courts. In 2019, an Oklahoma judge ordered J&J to pay a $465 million fine for downplaying the risks of opioids. J&J is appealing. juj/roc/to/lb
schema:headline
  • J&J and other drugmakers go on trial over US opioid crisis
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software